已入深夜,您辛苦了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!祝你早点完成任务,早点休息,好梦!

Tumor-activated IL-2 mRNA delivered by lipid nanoparticles for cancer immunotherapy

癌症免疫疗法 免疫疗法 连接器 癌症研究 体内 免疫系统 体外 信使核糖核酸 化学 分子生物学 生物 免疫学 生物化学 基因 生物技术 计算机科学 操作系统
作者
Yuhao Jiang,Yanhao Zhang,Chao Liu,Jinyu Liu,Wenliang Xue,Zihao Wang,Xinsong Li
出处
期刊:Journal of Controlled Release [Elsevier BV]
卷期号:368: 663-675 被引量:13
标识
DOI:10.1016/j.jconrel.2024.03.016
摘要

Interleukin-2 (IL-2) exhibits the unique capacity to modulate immune functions, potentially exerting antitumor effects by stimulating immune responses, making it highly promising for immunotherapy. However, the clinical use of recombinant IL-2 protein faces significant limitations due to its short half-life and systemic toxicity. To overcome these challenges and fully exploit IL-2's potential in tumor immunotherapy, this study reports the development of a tumor-activated IL-2 mRNA, delivered via lipid nanoparticles (LNPs). Initially, ionizable lipid U-101 derived nanoparticles (U-101-LNP) were prepared using microfluidic technology. Subsequent in vitro and in vivo delivery tests demonstrated that U-101-LNP achieved more effective transfection than the approved ALC-0315-LNP. Following this, IL-2F mRNAs, encoding fusion proteins comprising IL-2, a linker, and CD25 (IL-2Rα), were designed and synthesized through in vitro transcription. A cleavable linker, consisting of the peptide sequence SGRSEN↓IRTA, was selected for cleavage by matrix metalloproteinase-14 (MMP-14). IL-2F mRNA was then encapsulated in U-101-LNP to create U-101-LNP/IL-2F mRNA complexes. After optimization, assessments of expression efficiency, masking, and release characteristics revealed that IL-2F with linker C4 demonstrated superior performance. Finally, the antitumor activity of IL-2F mRNA was evaluated. The results indicated that U-101-LNP/IL-2F mRNA achieved the strongest antitumor effect, with an inhibition rate of 70.3%. Immunohistochemistry observations revealed significant expressions of IL-2, IFN-γ, and CD8, suggesting an up-regulation of immunomodulation in tumor tissues. This effect could be ascribed to the expression of IL-2F, followed by the cleavage of the linker under the action of MMP-14 in tumor tissue, which sustainably releases IL-2. H&E staining of tissues treated with U-101-LNP/IL-2F mRNA showed no abnormalities. Further evaluations indicated that the U-101-LNP/IL-2F mRNA group maintained proper levels of inflammatory factors without obvious alterations in liver and renal functions. Taken together, the U-101-LNP/IL-2F mRNA formulation demonstrated effective antitumor activity and safety, which suggests potential applicability in clinical immunotherapy.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
echo发布了新的文献求助10
刚刚
知犯何逆完成签到 ,获得积分10
1秒前
3秒前
符昱发布了新的文献求助10
3秒前
sandra发布了新的文献求助10
4秒前
善学以致用应助江桥采纳,获得10
4秒前
SSS发布了新的文献求助30
8秒前
8秒前
天真之桃完成签到,获得积分10
9秒前
Johnson完成签到 ,获得积分10
11秒前
11秒前
13秒前
14秒前
14秒前
励志发布了新的文献求助10
14秒前
song发布了新的文献求助10
14秒前
刘蕾驳回了英姑应助
15秒前
16秒前
17秒前
18秒前
江桥发布了新的文献求助10
18秒前
汉堡包应助tian采纳,获得30
18秒前
英姑应助科研通管家采纳,获得10
20秒前
20秒前
英俊的铭应助科研通管家采纳,获得10
20秒前
20秒前
科研通AI2S应助科研通管家采纳,获得10
20秒前
20秒前
20秒前
20秒前
20秒前
小犁牛完成签到 ,获得积分10
22秒前
Lucas应助cxysss采纳,获得10
22秒前
Jemma发布了新的文献求助10
23秒前
25秒前
26秒前
xiaofeiyan发布了新的文献求助40
26秒前
量子星尘发布了新的文献求助10
26秒前
落后盼望发布了新的文献求助10
28秒前
ZJHYNL完成签到,获得积分10
29秒前
高分求助中
A new approach to the extrapolation of accelerated life test data 1000
Picture Books with Same-sex Parented Families: Unintentional Censorship 700
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
Nucleophilic substitution in azasydnone-modified dinitroanisoles 500
不知道标题是什么 500
Indomethacinのヒトにおける経皮吸収 400
Phylogenetic study of the order Polydesmida (Myriapoda: Diplopoda) 370
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3976455
求助须知:如何正确求助?哪些是违规求助? 3520548
关于积分的说明 11203728
捐赠科研通 3257156
什么是DOI,文献DOI怎么找? 1798618
邀请新用户注册赠送积分活动 877819
科研通“疑难数据库(出版商)”最低求助积分说明 806523